Rubicon Research Limited's 27th AGM: Key Resolutions Passed, Including Merger and ESOP Plan
Rubicon Research Limited's 27th AGM on August 26, 2026, approved financial statements, a final dividend, director re-appointment, and director remuneration. Key approvals included the ESOP 2026 plan and its extension to subsidiaries. A significant resolution was the merger of KIA Health Tech Private Limited with Rubicon Research Limited.
The approval of the merger of a subsidiary and the ESOP plan are significant strategic decisions that will impact the company's structure and employee incentives. The adoption of financial statements and dividend declaration are also material events for shareholders.
All resolutions, including financial statement adoption, dividend declaration, director appointments, ESOP plan, and a merger, were passed with a high majority, indicating strong shareholder confidence and support.
Rubicon Research Limited held its 27th Annual General Meeting (AGM) on August 26, 2026, where shareholders voted on several key resolutions. The meeting, conducted via video conferencing, saw the approval of Audited Standalone and Consolidated Financial Statements for the fiscal year ended March 31, 2026, along with the declaration of a final dividend for the same period.
Shareholders also re-appointed Mrs. Pratibha Pilgaonkar as a Director liable to retire by rotation and approved the remuneration payable to Non-Executive Independent Directors. Significant approvals included the Rubicon Research Limited Stock Options Plan 2026 (ESOP 2026) for eligible employees, and its extension to employees of subsidiaries. Furthermore, a scheme for the merger of wholly-owned subsidiary KIA Health Tech Private Limited with Rubicon Research Limited, under Section 233 of the Companies Act, 2013, was also approved by the requisite majority.
The AGM also saw the appointment of M/s. BNP and Associates as the Secretarial Auditors for the company. The voting results, compiled by Scrutinizer Sunny Gogiya of SGGS & Associates, indicated overwhelming support for all resolutions, with over 89% of the total votes polled in favour across all agenda items. The meeting commenced at 1:00 PM and concluded at 2:40 PM IST.
What to do with a filing like this
Rubicon Research Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Rubicon Research Limited. Read the original for the full detail.